Can a Pap smear be performed safely in a woman using a vaginal contraceptive ring (e.g., NuvaRing) without removing the ring, and are any modifications to the screening protocol required?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pap Smear with Vaginal Ring

The vaginal contraceptive ring does not need to be removed to perform a Pap smear, and no modifications to the standard cervical cancer screening protocol are required.

Standard Screening Protocol Applies

The available guidelines addressing cervical cancer screening do not identify the presence of a vaginal contraceptive ring as a factor requiring special consideration or protocol modification. 1 The sequence of specimen collection and the presence of vaginal devices have been specifically addressed in screening guidelines:

  • The sequence of cytology testing in relation to collection of other cervicovaginal specimens does not influence Pap test results or their interpretation. 1
  • Standard cervical cancer screening intervals and techniques remain unchanged regardless of contraceptive method used. 1

Practical Considerations During the Examination

While the ring does not interfere with specimen collection, certain practical steps optimize the procedure:

  • If mucopurulent discharge is present, the Pap test can be performed after careful removal of the discharge with a saline-soaked cotton swab. 1 This same principle applies if the ring causes any vaginal discharge—simply remove excess discharge before specimen collection.
  • The ring sits in the vaginal fornix and should not obstruct visualization of the cervix during speculum examination. 2, 3
  • If the ring temporarily interferes with cervical visualization, it can be briefly displaced within the vagina without removal, as the ring can be out of position for up to 3 hours without compromising contraceptive efficacy. 4

No Impact on Specimen Quality

The presence of the vaginal ring does not affect:

  • Cytology specimen adequacy or interpretation. 1
  • HPV testing, which can be performed using the same specimen collection techniques. 1
  • The reliability of screening results. 1

Common Pitfall to Avoid

Do not delay or postpone cervical cancer screening because a patient is using a vaginal contraceptive ring. The ring's presence is not listed among conditions that warrant postponement of cytology testing (unlike active menstruation with conventional cytology). 1 Unnecessary removal and reinsertion of the ring creates an opportunity for user error and potential contraceptive failure without providing any benefit to specimen quality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The contraceptive vaginal ring.

Seminars in reproductive medicine, 2010

Research

Vaginal ring contraception.

Contraception, 2011

Guideline

Contraceptive Vaginal Rings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How do you prescribe the NuvaRing (etonogestrel/released estradiol) vaginal ring to a healthy female of reproductive age for contraception or hormone replacement therapy?
What is the workup for a NuvaRing (etonogestrel and ethinyl estradiol) refill?
What are the hormone levels of the Nova ring (etonogestrel and ethinyl estradiol)?
Can Marvelon (Desogestrel and Ethinyl Estradiol) be taken continuously?
What are the current options and future developments for vaginal ring contraceptives, such as NuvaRing (etonogestrel and ethinyl estradiol), in terms of efficacy, safety, and alternatives like intrauterine devices (IUDs)?
For a 45‑year‑old adult with high‑risk factors (e.g., long‑term smoking, family history of cancer), should I order the SPOT‑MAS (blood‑based multi‑cancer early‑detection) test, and what are the recommended follow‑up actions for positive or negative results?
In an ICU patient with suspected bacterial infection (e.g., ventilator‑associated pneumonia, hospital‑acquired pneumonia, or sepsis of unknown source), what empiric broad‑spectrum antibiotic regimen should be started, considering likely source, local resistance patterns, prior colonisation with multidrug‑resistant organisms, recent antibiotic exposure, and renal or hepatic dysfunction, and what alternatives are appropriate if vancomycin cannot be used?
How is Dandy‑Walker variant diagnosed and managed in a child or adolescent presenting with developmental delay, ataxia, and signs of increased intracranial pressure?
What is the step‑by‑step approach to diagnosing heart failure?
Is pitavastatin 2 mg comparable to rosuvastatin 5 mg for LDL‑cholesterol lowering in adults without renal or hepatic impairment or statin intolerance?
Is a normal baseline pressure of the internal anal sphincter (IAS) or external anal sphincter (EAS) required for male orgasm and sexual arousal?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.